MDT: Analysis & Opinions

  1. BSX Commences U.S. INTREPID Trial - Analyst Blog

    June 18, 2013
    Boston Scientific initiates clinical trial for its Vercise DBS System in the U.S.
  2. German Court Rules in Favor of MDT - Analyst Blog

    June 17, 2013
    Recently, Medtronic won a patent infringement case over its peer Edwards LifeSciences.
  3. St. Jude Expands Neuro Offerings - Analyst Blog

    June 10, 2013
    St. Jude has entered into an exclusive distribution agreement with Spinal Modulation to sell its Axium ...
  4. Medtronic Still Reporting Weak Growth, But A Relatively ...

    May 22, 2013
    Medtronic continues to suffer with weak core markets, but business seems to be getting slowly better and valuation ...
  5. In A Growth-Starved Sector, Becton Dickinson Rules

    May 03, 2013
    Becton Dickinson is a great business, but investors seem to be too willing to overpay for today's relatively ...
  6. It Gets A Little Harder From Here For Covidien

    April 29, 2013
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  7. Broad Weakness Makes It Harder To Like St. Jude Today

    April 18, 2013
    Although I do believe the long-term expectations for St. Jude are increasingly beatable, this could be a frustrating ...
  8. Pharma Is Doing All The Pulling For Johnson & Johnson

    April 17, 2013
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  9. Earnings Preview: Medtronic - Analyst Blog

    February 15, 2013
    Leading medical devices company Medtronic (MDT) is scheduled to report its first quarter fiscal 2013 results before ...
  10. Hanger Beats Squarely; Profit Soars - Analyst Blog

    February 14, 2013
    Hanger Inc.'s (HGR) adjusted earnings of 58 cents per share for the fourth quarter of 2012 were 2 cents above the ...
  11. CE Mark for BSX's Promus Premier - Analyst Blog

    February 13, 2013
    Boston Scientific (BSX) has expanded its drug eluting stent ("DES") portfolio with the CE Mark approval for the ...
  12. Milestone for St. Jude's Heart Implant - Analyst Blog

    February 08, 2013
    Medical devices major St. Jude Medical Inc. (STJ) has reached yet another important clinical landmark by registering ...
  13. Medtronic Initiates Clinical Study - Analyst Blog

    January 30, 2013
    Leading medical device player Medtronic Inc. (MDT) continues to focus on the promising neuromodulation business. The ...
  14. Mixed Quarter for Boston Scientific - Analyst Blog

    January 29, 2013
    Boston Scientific (BSX) reported a net income of $60 million or 4 cents per share in the fourth quarter of 2012, a ...
  15. Microsemi's EPS Lags, Outlook Weak - Analyst Blog

    January 28, 2013
    Microsemi Corporation's (MSCC) adjusted earnings per share (EPS) for the first quarter of fiscal 2013 came in at 41 ...
  16. Acorda Gets US Army Support - Analyst Blog

    January 25, 2013
    Acorda Therapeutics, Inc. (ACOR) recently announced that it has been awarded a research contract worth $2.67 million ...
  17. Medtronic Ends SFA II Enrollment - Analyst Blog

    January 24, 2013
    Medtronic Inc. (MDT) has further strengthened its endovascular business. Recently, this leading medical devices ...
  18. St. Jude Beats Estimates - Analyst Blog

    January 23, 2013
    St. Jude Medical's (STJ) fourth-quarter adjusted earnings per share of 92 cents topped the Zacks Consensus Estimate ...
  19. CE Mark for St. Jude's Products - Analyst Blog

    January 22, 2013
    St. Jude Medical (STJ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial ...
  20. Stryker Follows Its Rivals With A Big Investment In China

    January 22, 2013
    Stryker's acquisition of Trauson is the right deal at the right time.
Marketplace
Trading Center